Chinese researchers find new way to lower lipid levels
BEIJING, Aug. 8 (Xinhua) -- Chinese researchers have found that inhibiting a kind of receptor in liver could decrease lipid levels in serum and liver, thereby reducing cardiovascular disease risk, according to a study paper published in the journal Nature.
The receptor, ASGR1, is exclusively expressed in liver, said the paper. It added that little has been known how the receptor affects the metabolism of cholesterol, whose accumulation can lead to an increased risk of cardiovascular diseases. Lipid-lowering is necessary to prevent and treat the diseases.
A research team from the Wuhan University found that inhibiting ASGR1 could promote the excretion of cholesterol into the bile and further excretion through feces, thus reducing lipid levels in serum and liver.
Based on the research results, the team developed an anti-ASGR1 neutralizing antibody, which could efficiently lower lipid levels by increasing cholesterol excretion, said the paper.
The antibody showed synergetic effects with widely used lipid-lowering drugs such as atorvastatin, the paper added.
Photos
Related Stories
- In pics: Science and technology museums arouse the interest of rural students in central China’s Henan
- Researchers discover earliest brood care in insects
- Science serves as bedrock of China's targeted epidemic control
- China unveils major sci-tech issues of 2022
- 10 years of China's sci-tech progress
- Chinese scientists make notable discovery on potato genome sequences
- Nation to open sci-tech sector wider to world while continuing pursuit of indigenous innovation: minister
- China's sci-tech development in the past 10 years
- China's science academy to hold virtual exhibitions
- About Bionic Robotic Fish
Copyright © 2022 People's Daily Online. All Rights Reserved.